| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 3.256 | 6.157 | 11.400 | 45.577 | 97.209 | 96.127 |
| Total Income - EUR | - | - | - | - | 3.256 | 6.157 | 11.405 | 45.582 | 97.233 | 98.470 |
| Total Expenses - EUR | - | - | - | - | 562 | 83 | 960 | 771 | 10.965 | 31.301 |
| Gross Profit/Loss - EUR | - | - | - | - | 2.694 | 6.074 | 10.445 | 44.812 | 86.268 | 67.169 |
| Net Profit/Loss - EUR | - | - | - | - | 2.596 | 5.899 | 10.103 | 43.676 | 85.296 | 64.215 |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Ama Oncology S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 0 | 760 | 2.465 | 40.630 | 55.646 |
| Current Assets | - | - | - | - | 2.872 | 6.667 | 10.506 | 52.830 | 80.780 | 32.450 |
| Inventories | - | - | - | - | 6 | 6 | 0 | 0 | 0 | 567 |
| Receivables | - | - | - | - | 464 | 552 | 1.558 | 36.564 | 34.674 | 12.431 |
| Cash | - | - | - | - | 2.402 | 6.109 | 8.949 | 16.266 | 46.106 | 19.451 |
| Shareholders Funds | - | - | - | - | 2.638 | 6.419 | 10.315 | 43.753 | 96.569 | 84.105 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 235 | 247 | 951 | 11.542 | 25.011 | 4.316 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8610 - 8610" | |||||||||
| CAEN Financial Year |
8610
|
|||||||||
Comments - Ama Oncology S.r.l.